Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Christopher Yea currently holds 228,759 shares of KalVista Pharmaceuticals, Inc. (KALV), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Christopher Yea has been a net seller of KALV stock. They have purchased $0 and sold $3.8M worth of shares.
Christopher Yea's most recent insider trade was on May 22, 2026, when they sold 2,358 shares at $26.78 per share.
Christopher Yea serves as Executive at KalVista Pharmaceuticals, Inc. (KALV). They have executed 99 insider transactions totaling $3.8M over their tenure at the company.
Christopher Yea holds the position of Executive at KalVista Pharmaceuticals, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 10 years and currently hold a stake valued at $0.
Christopher Yea has shown a selling trading pattern, with $0 in total purchases and $3.8M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Christopher Yea was on Jul 9, 2025, when they sold $474.6K worth of KALV shares. This transaction involved 30,250 shares at $15.69 per share.
Christopher Yea currently owns 228,759 shares of KalVista Pharmaceuticals, Inc. (KALV), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Christopher Yea's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Christopher Yea has 99 Form 4 filings on record as an insider at KalVista Pharmaceuticals, Inc..
Set alerts for Christopher Yea and 40,000+ other insiders.